KDM3A and gastric cancer: Consistent with previous research, we observed a significant increase in the infiltration of CD4 T cells, CD8 T cells, and NK cells in KDM3A‐ablated tumors, suggesting that targeting KDM3A could be a promising strategy for reversing the non‐MSI TME in gastric cancer.[22]